Mouse models of hepatocarcinogenesis: what can we learn for the prevention of human hepatocellular carcinoma?

Oncotarget

Volumn 1, Issue 5, 2010, Pages 373-378

  Vucur, Mihael ^a   Roderburg, Christoph ^b   Bettermann, Kira ^b   Tacke, Frank ^b   Heikenwalder, Mathias ^b   Trautwein, Christian ^b   Luedde, Tom ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; AUTACOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAP KINASE KINASE KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE;

ANIMAL; ARTICLE; CELL TRANSFORMATION; DISEASE MODEL; DRUG EFFECT; ENZYMOLOGY; GENETICS; HEPATITIS; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; HEPATITIS; HUMANS; INFLAMMATION MEDIATORS; LIVER; LIVER NEOPLASMS; MAP KINASE KINASE KINASES; MICE; MICE, KNOCKOUT; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 79957480596     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.170     Document Type: Article

References (0)